Rockland Immunochemicals, Inc. CSO Testifies on Scientific Reproducibility Issues at National Academies Session -- MEDICA - World Forum for Medicine

08/01/2018

Rockland Immunochemicals, Inc.

Rockland Immunochemicals, Inc. CSO Testifies on Scientific Reproducibility Issues at National Academies Session

Rockland Immunochemicals, Inc. announced today that Chief Science Officer, Dr. Carl Ascoli testified at the National Academies of Sciences, Engineering and Medicine’s third of six public session on Reproducibility and Replicability in Science on April 18th.


The National Academies are charged by Congressional mandate to explore the issues of reproducibility and replication in scientific and engineering research. The committee, composed of 15 subject matter experts, will assess what is known and identify areas that need more information regarding issues of replication and reproducibility; consider if the lack of replication and reproducibility impacts the health of science and the public’s perception; and draw conclusions and make recommendations to Congress that may have consequences affecting levels of government funding.

Exhibitor Data Sheet